Navigation Links
'Publication Bias' Casts Doubt on Value of Antidepressants for Autism
Date:4/23/2012

By Jenifer Goodwin
HealthDay Reporter

MONDAY, April 23 (HealthDay News) -- Studies that show a type of antidepressant eases autism symptoms are more likely to get published in medical journals than studies concluding the drugs don't improve common behaviors such as rocking and hand-flapping, new research says.

That "publication bias" may mean that physicians believe the medications -- known as selective serotonin reuptake inhibitors (SSRIs) -- are more effective than they really are for children with these behaviors. Indeed, when researchers combined the data from published studies and those that never made it into print, the new analysis showed that SSRIs don't help repetitive behaviors much at all.

"At least from what we have right now, we need more information to determine if SSRIs are useful in treating repetitive behavior," said study author Melisa Carrasco, of the neuroscience graduate program at the University of Michigan in Ann Arbor. "I don't think we're trying to say they should not be used at all in autism. There is some compelling evidence toward their use in treating anxiety disorders in autism."

The study, in the May print issue of Pediatrics, appears online April 23.

The study also calls into question the effectiveness of current methods used to evaluate drugs, particularly pediatric drugs, in the United States. One expert said the findings have implications for countless other drug trials for other conditions.

It's long been recognized that drug trials that show the drug is effective are more likely to be published in peer-reviewed journals, where the results are widely read and disseminated to doctors, said Dr. Scott Denne, a professor of pediatrics at Indiana University School of Medicine, who wrote an accompanying editorial.

"Positive studies are exciting and potentially groundbreaking. Negative studies are not particularly exciting and at least in the estimation of both physicians and investigators, they don't really change anything, even though that isn't necessarily true," Denne said.

Current U.S. law requires that investigators submit a summary of the results of drug trials on ClinicalTrials.gov, a national registry of clinical studies. But often, researchers don't submit their results, and the information is never published on the government website, he said.

"A substantial number of trials are not having the results posted anywhere," Denne said. This deprives pediatric researchers and the public of valuable information, and may mean that trials are unnecessarily repeated.

Carrasco and her colleagues searched PubMed (a U.S. National Institutes of Health database) and ClinicalTrials.gov for randomized, double-blind, placebo-controlled trials (considered the gold standard of research) on using SSRIs to treat repetitive behavior in people with autism. Researchers identified five published trials and five unpublished trials marked as completed on ClinicalTrials.gov.

A meta-analysis (pooled analysis) of the published studies found a small but significant improvement in repetitive behaviors, including obsessions and compulsions, among autistic kids treated with SSRIs. When the unpublished studies were included, that benefit vanished.

About one in 88 U.S. children has autism, a neurodevelopment disorder characterized by problems with social interaction, communication and restricted interests and behaviors. That includes repetitive behaviors, such as arm-flapping or head-banging; having an obsessive interest in one topic; having a need to stick to a specific ritual or routine; and experiencing distress or agitation when that routine gets disrupted.

More information

To learn more about autism treatments, visit Autism Speaks.

SOURCE: Melisa Carrasco, Ph.D., recent graduate, neuroscience graduate program, University of Michigan, Ann Arbor; Scott Denne, M.D., professor, pediatrics, Indiana University School of Medicine, Indianapolis; May 2012 Pediatrics


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Video publication goes viral
2. Oxford University Press acquires 2 journals from Preston Publications
3. Charles to receive GSAs 2011 Richard Kalish Innovative Publication Award
4. IASLC welcomes publication of CT screening results from National Lung Screening Trial
5. ACP Publications take home awards for publishing excellence
6. Elsevier Health Middle East announces publication of first bilingual medical title
7. PSA screening declines following publication of large trials, guidelines
8. Publication of World Health Report 2000 an act of remarkable courage, says school expert
9. Trainee publication highlights success of US-China agricultural injury research training project
10. The International Association of Anesthesiologists Places its Top Doctors in the Renowned Medical Publication, The Leading Physicians of the World.
11. HealthLeaders Magazine Named Publication of the Year – ASHPE's Most Prestigious Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Publication Bias' Casts Doubt on Value of Antidepressants for Autism
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, co-owner ... in Frederick, MD. Judy says, “I am passionate about sharing Reiki as a ... very difficult and challenging time.” , A Certified Medical Reiki™ Master trained by ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation ... and college Bible teacher residing in North Carolina with his wife, Anna Marie. He ... them with six grandchildren. David is also the author of “Shadow and Substance.” , ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... their communities, 16 more public health departments have been awarded national accreditation through ... 4.5 million people into the expanding network of communities across the nation whose ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The IoT (Internet ... WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... the IoT will have a value anywhere from $4 trillion to $11 trillion dollars ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 23, 2017  Mirabilis Medical, a ... for non-invasive surgery, announced today CE Mark authorization ... of uterine fibroids throughout the European Union.  The ... from the US Food and Drug Administration to ... in the United States.  The Mirabilis System combines ...
(Date:3/24/2017)... GENEVA , March 24, 2017 ... revitalizes efforts to develop sutezolid as effective response to ... Day, TB Alliance and the Medicines Patent Pool (MPP) ... sutezolid, an antibiotic drug candidate which demonstrated encouraging results ... of sutezolid in combination with other TB drugs and ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 Research ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... CAGR of around 6.9% over the next decade to reach approximately ... market estimates and forecasts for all the given segments on global ...
Breaking Medicine Technology: